ATELVIA DR 35 MG TABLET

What it is

ATELVIA DR 35 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as risedronate sodium, under the trade name “Atelvia”.

FDA gives its dosage form as tablet, delayed release and its route as oral.

The labeler, the company named on the label, is Allergan, Inc.

FDA’s Established Pharmacologic Class for it is Bisphosphonate.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00430-0979-03.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1,914.24 for 30 tablets (30 × $63.80786 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $30.67721 per EA filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What NADAC measures · Why 30 tablets · NADAC explanation codes

The NDC

• 00430-0979-03 · Allergan, Inc. · $63.80786 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

6 other products in the NADAC file share the FDA nonproprietary name risedronate sodium with ATELVIA DR 35 MG TABLET.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-21, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $63.80786 per EA filed.

Of the 14 other products in FDA’s Bisphosphonate class priced per EA, 2 have a higher middle NADAC price and 12 a lower one. The one in the middle is IBANDRONATE SODIUM 150 MG TAB, at $2.67507 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
• Is a generic version available, and would it suit me? NADAC lists a generic with the same ingredient, strength and dosage form by FDA: RISEDRONATE SOD DR 35 MG TAB. Ask your pharmacist or prescriber; do not switch on your own.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.